Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Fig. 1

Representative images of 5mC immunoreactivity in malignant and non-malignant prostate tissue samples. a TMA core containing both malignant and NM prostate glands, illustrating reduced 5mC levels in malignant (IHC score = 1, arrowheads) compared to NM (IHC score = 2, arrows) glands. b Strong 5mC staining in a malignant core (IHC score = 2). c Moderate 5mC staining in a malignant core (IHC score = 1). d Weak 5mC staining in a NM core (IHC score = 0)

Back to article page